Merck KGaA (XTER:MRK) Net Income Including Noncontrolling Interests : €2,836 Mil (TTM As of Dec. 2023)

View and export this data going back to 1995. Start your Free Trial

What is Merck KGaA Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Merck KGaA's Net Income Including Noncontrolling Interests for the three months ended in Dec. 2023 was €588 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Dec. 2023 was €2,836 Mil.

Merck KGaA Net Income Including Noncontrolling Interests Historical Data

The historical data trend for Merck KGaA's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck KGaA Net Income Including Noncontrolling Interests Chart

Merck KGaA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Income Including Noncontrolling Interests

Get a 7-Day Free Trial

1,323.00

1,994.00

3,065.00

3,340.00

2,834.00

Merck KGaA Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Net Income Including Noncontrolling Interests	Get a 7-Day Free Trial															660.00	800.00	707.00	741.00	588.00

Merck KGaA Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €2,836 Mil.

Merck KGaA Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of Merck KGaA's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.

Merck KGaA (XTER:MRK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck KGaA (XTER:MRK) » Definitions » Net Income Including Noncontrolling Interests

Comparable Companies

Traded in Other Exchanges

MKKGY:USA MKGAF:USA MRK:Italy MRKd:UK 0O14:UK MRCK:Austria

Address

Frankfurter Strasse 250, Darmstadt, HE, DEU, 64293

Website

https://www.emdgroup.com

Merck KGaA operates in three main segments: life sciences, performance materials, and healthcare. The life sciences segment (47% of 2022 sales) primarily provides laboratory consumables and services to researchers in academia and applied fields, including the biopharmaceutical industry. In the healthcare segment (35%), Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In its electronics segment (18%), the company offers specialty materials to manufacture a variety of products, such as semiconductors, flat-screen televisions, automobiles, and cosmetics. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.

Executives

Belén Garijo Lopez	Chair of the Executive Board
Peter Guenter	Member of the Executive Board
Dr. Matthias Heinzel	Member of the Executive Board
Dr. Marcus Kuhnert	Board of Directors